#015

After decades of failed drug trials, two new drugs have emerged in slowing memory loss associated with Alzheimer's disease: Leqembi and Donanemab. In Episode #015 I deep dive into novel Alzheimer's therapies to discuss their effectiveness, safety, and how to find out if you're at risk.


Chapters:


(0:00) Introduction


(2:00) Who's most at risk of Alzheimer's Disease?


(5:52) The Amyloid Hypothesis


(7:14) Leqembi approved by FDA


(9:16) Donanenmab may be next


(12:10) Alzheimer's drugs, brain bleeding, and death


(16:01) How do you know if you have Alzheimer's?


(21:20) Dementia and CTE


(22:49) Do taking smart drugs make us more productive? Is it worth the risk?


(27:00) The Connect - viewers' comments from previous episodes


Show Notes:


Alzheimer’s drug being tested Leqembi or Lecanemab


https://www.abc.net.au/news/2023-07-0...


Donanemab:


https://www.abc.net.au/news/2023-05-0...


Systematic failure of Alzheimer’s drug trials:


https://www.abc.net.au/news/health/20...


Are these drugs safe?


https://www.science.org/content/artic...


Symptoms of Alzheimer’s:


https://www.dementia.org.au/about-dem...


Mini Mental State Examination (MMSE)


https://cgatoolkit.ca/Uploads/Content...


CTE in female athlete:


https://theconversation.com/australia...


Smart drugs make you dumb:


https://theconversation.com/smart-dru...





Thanks for reading BioLab Collective with Jack Wang! Subscribe for free to receive new posts and support my work.





Get full access to BioLab Collective with Jack Wang at biolabcollective.substack.com/subscribe (https://biolabcollective.substack.com...)